Timothy J Purwin - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Timothy J Purwin

Showing results (41-50 of 43) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 43 results.

Cancer Research|July 31, 2025

Elevated Transglutaminase-2 in SOX10-Deficient Melanoma Promotes Tumor Onset and Decreases Intratumoral CD4+ T CellsSigne Caksa, Timothy J Purwin, Dan A Erkes, et al.

Nature Communications|March 17, 2022

Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanomaClaudia Capparelli, Timothy J Purwin, McKenna Glasheen, et al.

The Journal of Clinical Investigation|September 16, 2025

Elevated NR2F1 underlies the persistence of invasive disease after treatment of BRAF-mutant melanomaManoela Tiago, Timothy J Purwin, Casey D Stefanski, et al.

Pageof 5

Search research articles

Showing results (41-50 of 43) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 43 results.

Cancer Research|July 31, 2025

Elevated Transglutaminase-2 in SOX10-Deficient Melanoma Promotes Tumor Onset and Decreases Intratumoral CD4+ T CellsSigne Caksa, Timothy J Purwin, Dan A Erkes, et al.

Nature Communications|March 17, 2022

Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanomaClaudia Capparelli, Timothy J Purwin, McKenna Glasheen, et al.

The Journal of Clinical Investigation|September 16, 2025

Elevated NR2F1 underlies the persistence of invasive disease after treatment of BRAF-mutant melanomaManoela Tiago, Timothy J Purwin, Casey D Stefanski, et al.

Pageof 5